HomeVINC • NASDAQ
Vincerx Pharma Inc
Follow
$0.61
8.29%
After Hours:(1.97%)+0.012
$0.62
Closed: Apr 4, 7:58:23 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.79M | -18.90% |
Net income | -7.84M | 12.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.78M | 18.92% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.09M | -51.51% |
Total assets | 14.95M | -43.12% |
Total liabilities | 5.84M | -44.58% |
Total equity | 9.11M | — |
Shares outstanding | 1.68M | — |
Price to book | 0.11 | — |
Return on assets | -106.83% | — |
Return on capital | -138.53% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.84M | 12.92% |
Cash from operations | -6.38M | 4.00% |
Cash from investing | 1.37M | -90.88% |
Cash from financing | 0.00 | — |
Net change in cash | -4.98M | -159.27% |
Free cash flow | -2.82M | 7.03% |
Previous close
$0.66
Day range
$0.59 - $0.66
Year range
$0.48 - $136.63
Market cap
3.32M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
42
